Integrative phenotyping of glycemic responders upon clinical weight loss using multi-omics

Abstract Weight loss aims to improve glycemic control in obese but strong variability is observed. Using a multi-omics approach, we investigated differences between 174 responders and 201 non-responders, that had lost >8% body weight following a low-caloric diet (LCD, 800 kcal/d for 8 weeks). The...

Full description

Bibliographic Details
Main Authors: Armand Valsesia, Anirikh Chakrabarti, Jörg Hager, Dominique Langin, Wim H. M. Saris, Arne Astrup, Ellen E. Blaak, Nathalie Viguerie, Mojgan Masoodi
Format: Article
Language:English
Published: Nature Portfolio 2020-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-020-65936-8
_version_ 1818735969887584256
author Armand Valsesia
Anirikh Chakrabarti
Jörg Hager
Dominique Langin
Wim H. M. Saris
Arne Astrup
Ellen E. Blaak
Nathalie Viguerie
Mojgan Masoodi
author_facet Armand Valsesia
Anirikh Chakrabarti
Jörg Hager
Dominique Langin
Wim H. M. Saris
Arne Astrup
Ellen E. Blaak
Nathalie Viguerie
Mojgan Masoodi
author_sort Armand Valsesia
collection DOAJ
description Abstract Weight loss aims to improve glycemic control in obese but strong variability is observed. Using a multi-omics approach, we investigated differences between 174 responders and 201 non-responders, that had lost >8% body weight following a low-caloric diet (LCD, 800 kcal/d for 8 weeks). The two groups were comparable at baseline for body composition, glycemic control, adipose tissue transcriptomics and plasma ketone bodies. But they differed significantly in their response to LCD, including improvements in visceral fat, overall insulin resistance (IR) and tissue-specific IR. Transcriptomics analyses found down-regulation in key lipogenic genes (e.g. SCD, ELOVL5) in responders relative to non-responders; metabolomics showed increase in ketone bodies; while proteomics revealed differences in lipoproteins. Findings were consistent between genders; with women displaying smaller improvements owing to a better baseline metabolic condition. Integrative analyses identified a plasma omics model that was able to predict non-responders with strong performance (on a testing dataset, the Receiving Operating Curve Area Under the Curve (ROC AUC) was 75% with 95% Confidence Intervals (CI) [67%, 83%]). This model was based on baseline parameters without the need for intrusive measurements and outperformed clinical models (p = 0.00075, with a +14% difference on the ROC AUCs). Our approach document differences between responders and non-responders, with strong contributions from liver and adipose tissues. Differences may be due to de novo lipogenesis, keto-metabolism and lipoprotein metabolism. These findings are useful for clinical practice to better characterize non-responders both prior and during weight loss.
first_indexed 2024-12-18T00:29:42Z
format Article
id doaj.art-b17731f6b55c46028452475f12f8184d
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-18T00:29:42Z
publishDate 2020-06-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-b17731f6b55c46028452475f12f8184d2022-12-21T21:27:10ZengNature PortfolioScientific Reports2045-23222020-06-0110111410.1038/s41598-020-65936-8Integrative phenotyping of glycemic responders upon clinical weight loss using multi-omicsArmand Valsesia0Anirikh Chakrabarti1Jörg Hager2Dominique Langin3Wim H. M. Saris4Arne Astrup5Ellen E. Blaak6Nathalie Viguerie7Mojgan Masoodi8Nestlé Institute of Health SciencesNestlé Institute of Health SciencesNestlé Institute of Health SciencesINSERM, UMR 1048, Institute of Metabolic and Cardiovascular DiseasesDepartment of Human Biology, NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+(MUMC+)University of Copenhagen, Department of Nutrition, Exercise and Sports, Faculty of ScienceDepartment of Human Biology, NUTRIM, School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+(MUMC+)INSERM, UMR 1048, Institute of Metabolic and Cardiovascular DiseasesNestlé Institute of Health SciencesAbstract Weight loss aims to improve glycemic control in obese but strong variability is observed. Using a multi-omics approach, we investigated differences between 174 responders and 201 non-responders, that had lost >8% body weight following a low-caloric diet (LCD, 800 kcal/d for 8 weeks). The two groups were comparable at baseline for body composition, glycemic control, adipose tissue transcriptomics and plasma ketone bodies. But they differed significantly in their response to LCD, including improvements in visceral fat, overall insulin resistance (IR) and tissue-specific IR. Transcriptomics analyses found down-regulation in key lipogenic genes (e.g. SCD, ELOVL5) in responders relative to non-responders; metabolomics showed increase in ketone bodies; while proteomics revealed differences in lipoproteins. Findings were consistent between genders; with women displaying smaller improvements owing to a better baseline metabolic condition. Integrative analyses identified a plasma omics model that was able to predict non-responders with strong performance (on a testing dataset, the Receiving Operating Curve Area Under the Curve (ROC AUC) was 75% with 95% Confidence Intervals (CI) [67%, 83%]). This model was based on baseline parameters without the need for intrusive measurements and outperformed clinical models (p = 0.00075, with a +14% difference on the ROC AUCs). Our approach document differences between responders and non-responders, with strong contributions from liver and adipose tissues. Differences may be due to de novo lipogenesis, keto-metabolism and lipoprotein metabolism. These findings are useful for clinical practice to better characterize non-responders both prior and during weight loss.https://doi.org/10.1038/s41598-020-65936-8
spellingShingle Armand Valsesia
Anirikh Chakrabarti
Jörg Hager
Dominique Langin
Wim H. M. Saris
Arne Astrup
Ellen E. Blaak
Nathalie Viguerie
Mojgan Masoodi
Integrative phenotyping of glycemic responders upon clinical weight loss using multi-omics
Scientific Reports
title Integrative phenotyping of glycemic responders upon clinical weight loss using multi-omics
title_full Integrative phenotyping of glycemic responders upon clinical weight loss using multi-omics
title_fullStr Integrative phenotyping of glycemic responders upon clinical weight loss using multi-omics
title_full_unstemmed Integrative phenotyping of glycemic responders upon clinical weight loss using multi-omics
title_short Integrative phenotyping of glycemic responders upon clinical weight loss using multi-omics
title_sort integrative phenotyping of glycemic responders upon clinical weight loss using multi omics
url https://doi.org/10.1038/s41598-020-65936-8
work_keys_str_mv AT armandvalsesia integrativephenotypingofglycemicrespondersuponclinicalweightlossusingmultiomics
AT anirikhchakrabarti integrativephenotypingofglycemicrespondersuponclinicalweightlossusingmultiomics
AT jorghager integrativephenotypingofglycemicrespondersuponclinicalweightlossusingmultiomics
AT dominiquelangin integrativephenotypingofglycemicrespondersuponclinicalweightlossusingmultiomics
AT wimhmsaris integrativephenotypingofglycemicrespondersuponclinicalweightlossusingmultiomics
AT arneastrup integrativephenotypingofglycemicrespondersuponclinicalweightlossusingmultiomics
AT elleneblaak integrativephenotypingofglycemicrespondersuponclinicalweightlossusingmultiomics
AT nathalieviguerie integrativephenotypingofglycemicrespondersuponclinicalweightlossusingmultiomics
AT mojganmasoodi integrativephenotypingofglycemicrespondersuponclinicalweightlossusingmultiomics